Cardiovascular Calcification Market Growth Through 2030 Creates New Strategic Opportunities
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Cardiovascular Calcification Market Expansion From $2.05 Billion In 2026 To $2.78 Billion In 2030
The cardiovascular calcification market has experienced robust expansion in recent years. This market is projected to grow from $1.9 billion in 2025 to $2.05 billion in 2026, at a compound annual growth rate (CAGR) of 7.7%. Historically, its growth has been fueled by an aging population, the rising prevalence of cardiovascular diseases, the development of diagnostic imaging infrastructure, increased adoption of CT and MRI systems, and greater awareness of vascular calcification risks.
The cardiovascular calcification market size is anticipated to experience substantial expansion in the coming years. It is projected to reach a valuation of $2.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This projected growth during the forecast period is driven by several factors, including the escalating need for precise cardiovascular diagnostic tools, the increasing implementation of AI-supported imaging analysis, the broadening availability of minimally invasive diagnostic methods, rising financial commitments to preventive cardiology, and a heightened emphasis on early intervention approaches. Key trends characterizing this period encompass the wider embrace of sophisticated cardiovascular imaging techniques, the growing application of calcium scoring and risk assessment instruments, the expanding incorporation of artificial intelligence into diagnostic imaging, the spread of catheter-based diagnostic innovations, and a stronger emphasis on identifying diseases at early stages.
Download A Free Sample Report For Comprehensive Market Insights:
Cardiovascular Calcification Market Growth Drivers: What Factors Are Accelerating Expansion?
The increasing incidence of cardiovascular diseases is projected to stimulate the growth of the cardiovascular calcification market going forward. These conditions involve impairments to the heart and blood vessels, resulting in issues like heart disease, stroke, and elevated blood pressure. The rise in cardiovascular diseases is fueled by sedentary lifestyles and unhealthy dietary practices, which elevate risks such as hypertension, obesity, and arterial damage. Cardiovascular calcification contributes to addressing cardiovascular diseases by serving as an indicator of atherosclerosis and plaque buildup, thereby allowing for the early identification of heart and vessel damage and directing preventive or therapeutic interventions. As an illustration, in August 2025, the National Institutes of Health, a US-based government agency, predicted that from 2025 to 2050, cardiovascular prevalence is expected to climb by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Consequently, the escalating number of cardiovascular diseases is propelling the expansion of the cardiovascular calcification market.
#Cardiovascular Calcification Market Segment Landscape And Growth Potential
The cardiovascular calcification market covered in this report is segmented –
1) By Product Type: Imaging Systems; Atherectomy Devices; Stents; Transcatheter Valves
2) By Diagnosis: Computed Tomography (CT) Calcium Scoring; Echocardiography; Intravascular Ultrasound; Biomarkers
3) By Application: Coronary Artery Disease; Aortic Valve Stenosis; Peripheral Artery Disease; Chronic Kidney Disease (CKD) Related Vascular Calcification
4) By End User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Dialysis And Nephrology Centers
Subsegments:
1) By Imaging Systems: Magnetic Resonance Imaging; Computed Tomography Imaging; Ultrasound Imaging; Nuclear Imaging
2) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices
3) By Stents: Drug Eluting Stents; Bare Metal Stents; Bioabsorbable Stents; Balloon Expandable Stents
4) By Transcatheter Valves: Transcatheter Aortic Valves; Transcatheter Mitral Valves; Transcatheter Pulmonary Valves; Transcatheter Tricuspid Valves
Cardiovascular Calcification Market Trends: What Is Shaping Future Industry Growth?
Major companies within the cardiovascular calcification market are concentrating on developing innovative solutions, such as targeted intravascular shockwave energy delivery technology, with the aim of enhancing the treatment of severely calcified lesions by improving lesion crossing, vessel compliance, and success rates for procedures. This targeted intravascular shockwave energy delivery technology constitutes a catheter-based approach that emits controlled acoustic pressure waves within blood vessels to fragment calcified plaque, all while safeguarding adjacent soft tissue and maintaining vessel integrity. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device firm, introduced a novel forward intravascular lithotripsy platform in the US to revolutionize the management of challenging-to-cross calcified lesions. It operates by utilizing forward sonic pressure waves to fracture calcium in difficult-to-cross calcified peripheral artery lesions without the need for balloon inflation. Its primary aim is to facilitate safe catheter progression and vascular modification in intricate PAD cases, including CLTI, thereby yielding superior outcomes compared to conventional instruments. Data from the FORWARD PAD trial demonstrated key benefits, including 99% technical success, a low rate of major complications at 1.1%, diminished risks of perforation or embolization, and improved efficiency for treatments below the knee.
Cardiovascular Calcification Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the cardiovascular calcification market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Royal Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Shimadzu Corporation, HeartFlow Inc., Aidoc Ltd., Neusoft Medical Systems Co. Ltd., Medis Medical Imaging Systems B.V., Pie Medical Imaging B.V., Canon Medical Systems Corporation, Keya Medical Technology Co. Ltd., Coreline Soft Co. Ltd., FastWave Medical Inc., Cleerly Inc., United Imaging Healthcare Co. Ltd., Zebra Medical Vision Ltd., Circle Cardiovascular Imaging Inc
Access The Complete Cardiovascular Calcification Market Report:
Cardiovascular Calcification Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the cardiovascular calcification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular calcification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model